John W. Higuchi, Director at Lipocine, bought LPCN on Sep 30, 2026
Data as of Oct 16
- Traded
- Sep 30, 2026
- Disclosed
- Oct 1, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
LPCN since disclosure
−24.6%
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund
Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYJohn W. Higuchi DirectorLPCN Lipocine Inc.$19.4Kdisclosed Oct 1 · filed 2 days after the trade